Advertisement

Latest Articles

  • Neurobiological Mechanisms of Nicotine Reward and Aversion
    Open Access
    Neurobiological Mechanisms of Nicotine Reward and Aversion
    Lauren Wills, Jessica L. Ables, Kevin M. Braunscheidel, Stephanie P.B. Caligiuri, Karim S. Elayouby, Clementine Fillinger, Masago Ishikawa, Janna K. Moen and Paul J. Kenny
    Charles France, ASSOCIATE EDITOR
    Pharmacological Reviews January 2022, 74 (1) 271-310; DOI: https://doi.org/10.1124/pharmrev.121.000299
  • Open Access
    Organotypic and Microphysiological Human Tissue Models for Drug Discovery and Development—Current State-of-the-Art and Future Perspectives
    Sonia Youhanna, Aurino M. Kemas, Lena Preiss, Yitian Zhou, Joanne X. Shen, Selgin D. Cakal, Francesco S. Paqualini, Sravan K. Goparaju, Reza Zandi Shafagh, Johan Ulrik Lind, Carl M. Sellgren and Volker M. Lauschke
    Gunnar Schulte, ASSOCIATE EDITOR
    Pharmacological Reviews January 2022, 74 (1) 141-206; DOI: https://doi.org/10.1124/pharmrev.120.000238
  • Inhaled Medicines: Past, Present, and Future
    Open Access
    Inhaled Medicines: Past, Present, and Future
    Sandra Anderson, Paul Atkins, Per Bäckman, David Cipolla, Andrew Clark, Evangelia Daviskas, Bernd Disse, Plamena Entcheva-Dimitrov, Rick Fuller, Igor Gonda, Hans Lundbäck, Bo Olsson and Jeffry Weers
    Clive Page, ASSOCIATE EDITOR
    Pharmacological Reviews January 2022, 74 (1) 48-118; DOI: https://doi.org/10.1124/pharmrev.120.000108
  • The Yin and Yang of ERBB4: Tumor Suppressor and Oncoprotein
    Open Access
    The Yin and Yang of ERBB4: Tumor Suppressor and Oncoprotein
    Lauren M. Lucas, Vipasha Dwivedi, Jared I. Senfeld, Richard L. Cullum, Christopher P. Mill, J. Tyler Piazza, Ianthe N. Bryant, Laura J. Cook, S. Tyler Miller, James H. Lott, Connor M. Kelley, Elizabeth L. Knerr, Jessica A. Markham, David P. Kaufmann, Megan A. Jacobi, Jianzhong Shen and David J. Riese
    Eric Barker, ASSOCIATE EDITOR
    Pharmacological Reviews January 2022, 74 (1) 18-47; DOI: https://doi.org/10.1124/pharmrev.121.000381
  • Targeting Systemic Innate Immune Cells as a Therapeutic Avenue for Alzheimer Disease
    Vincent Pons and Serge Rivest
    Robert Dantzer, ASSOCIATE EDITOR
    Pharmacological Reviews January 2022, 74 (1) 1-17; DOI: https://doi.org/10.1124/pharmrev.121.000400

Pages

More

About Pharmacological Reviews

Pharmacological Reviews presents important review articles covering the broad spectrum of pharmacological research. Topics covered have included biochemical and cellular pharmacology, drug metabolism and disposition, renal pharmacology, neuropharmacology, behavioral pharmacology, clinical pharmacology, and toxicology. IUPHAR nomenclature reports are published here.

Current issue

Pharmacological Reviews is published continuously. Articles are added as they are ready. Quarterly issues are completed on or about the first business day of January, April, July, and October. Check this site for new content or sign up for content alerts.

Advertisement
For an alternate route to this Journal use this URL: http://intl-pharmrev.aspetjournals.org
Back to top